Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation

Biochemical and Biophysical Research Communications

Volumn 433, Issue 2, 2013, Pages 255-259

  Lee, Ha Young ^a,b   Kim, Sang Doo ^a   Baek, Suk Hwan ^c   Choi, Joon Hyuk ^c   Bae, Yoe Sik ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Dong A University   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

Author keywords

Foam cell; Formyl peptide receptor 2; Serum amyloid A

Indexed keywords

FORMYL PEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SERUM AMYLOID A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84877651628     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.002     Document Type: Article

References (35)

1. Miller Y.I., Choi S.H., Fang L., Tsimikas S. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis. Subcell. Biochem. 2010, 51:229-251.
2. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999, 99:3110-3117.
3. Endemann G., Stanton L.W., Maden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 1993, 268:11811-11816.
4. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296.
5. Liang M., Zhang P., Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 2007, 258:31-37.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
7. Cascieri M.A. The potential for novel anti-inflammatory therapies for coronary artery disease. Nat. Rev. Drug Discov. 2002, 1:122-130.
8. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007, 39:86-93.
9. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265:501-523.
10. Koga T., Torigoshi T., Motokawa S., Miyashita T., Maeda Y., Nakamura M., Komori A., Aiba Y., Uemura T., Yatsuhashi H., Ishibashi H., Eguchi K., Migita K. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett. 2008, 582:579-585.
11. Jijon H.B., Madsen K.L., Walker J.W., Allard B., Jobin C. Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 2005, 35:718-726.
12. Furlaneto C.J., Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 2000, 268:405-408.
13. Glurich I., Grossi S., Albini B., Ho A., Shah R., Zeid M., Baumann H., Genco R.J., De Nardin E. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin. Diagn. Lab. Immunol. 2002, 9:425-432.
14. Lewis K.E., Kirk E.A., McDonald T.O., Wang S., Wight T.N., O'Brien K.D., Chait A. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 2004, 110:540-545.
15. Lee H.Y., Kim S.D., Shim J.W., Lee S.Y., Lee H., Cho K.H., Yun J., Bae Y.S. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J. Immunol. 2008, 81:4332-4339.
16. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., Kwak J.Y., Bae Y.S. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 2005, 330:989-998.
17. Lee H.Y., Kim S.D., Shim J.W., Yun J., Kim K., Bae Y.S. Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2009, 380:313-317.
18. Lee H.Y., Kim S.D., Shim J.W., Kim H.J., Yun J., Baek S.H., Kim K., Bae Y.S. A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production. Exp. Mol. Med. 2010, 42:302-309.
19. Lee H.Y., Kim S.D., Baek S.H., Choi J.H., Cho K.H., Zabel B.A., Bae Y.S. Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation. Biochem. Biophys. Res. Commun. 2013, 10.1016/j.bbrc.2013.02.077.
20. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999, 189:395-402.
21. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008, 181:22-26.
22. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J. Leukocyte Biol. 2008, 83:1174-1180.
23. Christenson K., Bjorkman L., Tangemo C., Bylund J. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukocyte Biol. 2008, 83:139-148.
24. Lee J.G., Lim E.J., Park D.W., Lee S.H., Kim J.R., Baek S.H. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell. Signalling 2008, 20:2266-2275.
25. Badolato R., Johnston J.A., Wang J.M., McVicar D., Xu L.L., Oppenheim J.J., Kelvin D.J. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 1995, 155:4004-4010.
26. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 2004, 50:1788-1799.
27. Lee M.S., Yoo S.A., Cho C.S., Suh P.G., Kim W.U., Ryu S.H. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 2006, 177:5585-5594.
28. Cui Y.H., Le Y., Zhang X., Gong W., Abe K., Sun R., Van Damme J., Proost P., Wang J.M. Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha. Neurobiol. Dis. 2002, 10:366-377.
29. Chen K., Le Y., Liu Y., Gong W., Ying G., Huang J., Yoshimura T., Tessarollo L., Wang J.M. A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J. Immunol. 2010, 184:3331-3335.
30. Dufton N., Hannon R., Brancaleone V., Dalli J., Patel H.B., Gray M., D'Acquisto F., Buckingham J.C., Perretti M., Flower R.J. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 2010, 184:2611-2619.
31. Chiang N., Fierro I.M., Gronert K., Serhan C.N. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 2000, 191:1197-1208.
32. Lee H.Y., Jo S.H., Lee C., Baek S.H., Bae Y.S. Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Biochem. Pharmacol. 2006, 72:860-868.
33. Kim S.D., Kim Y.K., Lee H.Y., Kim Y.S., Jeon S.G., Baek S.H., Song D.K., Ryu S.H., Bae Y.S. The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J. Immunol. 2010, 185:4302-4310.
34. Bae Y.S., Yi H.J., Lee H.Y., Jo E.J., Kim J.I., Lee T.G., Ye R.D., Kwak J.Y., Ryu S.H. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J. Immunol. 2003, 17:6807-6813.
35. Tiffany H.L., Lavigne M.C., Cui Y.H., Wang J.M., Leto T.L., Gao J.L., Murphy P.M. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 2001, 276:23645-23652.